Prevalence of intimal pathogen burden in acute coronary syndromes;Prävalenz von intimalem pathogen burden bei akutem koronarsyndrom

Zeitschrift fur Kardiologie

Volumn 92, Issue 8, 2003, Pages 641-649

  Andrie R ^a   Braun, P ^b   Heinrich, K W ^b   Luderitz B ^a   Bauriedel, G ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Kaiser Wilhelm Krankenhaus   (Germany)

Author keywords

Acute coronary syndromes; Autoimmunity; Heat shock protein 60; Pathogen burden

Indexed keywords

HEAT SHOCK PROTEIN 60;

ACUTE DISEASE; ANGINA PECTORIS; ARTICLE; ATHERECTOMY; ATHEROSCLEROSIS; AUTOIMMUNITY; CARDIOVASCULAR DISEASE; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; HELICOBACTER PYLORI; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; PATHOGENESIS; PREVALENCE; PROTEIN EXPRESSION;

ACUTE DISEASE; AGED; ANGINA PECTORIS; ATHERECTOMY, CORONARY; AUTOIMMUNITY; CHAPERONIN 60; CHI-SQUARE DISTRIBUTION; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CYTOMEGALOVIRUS; DATA INTERPRETATION, STATISTICAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SYNDROME; TUNICA INTIMA;

EID: 0041323193     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-003-0951-2     Document Type: Article

References (38)

1. Abdelmeguid AE, Ellis SG, Sapp SK, Simpendorfer C, Franco I, Whitlow PL (1994) Directional atherectomy in unstable angina. J Am Coll Cardiol 24:46-54
2. Andrié R, Maylahn M, Braun P, Lü-deritz B, Bauriedel G (2002) C-reaktives Protein in koronarem Plaquegewebe - Prävalenz bei akutem Koronarsyndrom. Z Kardiol 91:913-920
3. Bauriedel G, Andrié R, Likungu JA, Welz A, Braun P, Welsch U, Lüderitz B (1999) Persistenz von Chlamydia pneumoniae in koronarem Plaquegewebe - Ein Beitrag zur Infektionsund Immunhypothese bei instabiler Angina pectoris. Dtsch Med Wochenschr 124:1408-1413
4. Bauriedel G, Hutter R, Welsch U, Bach R, Sievert H, Lüderitz B (1999) Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability. Cardiovasc Res 41:480-488
5. Benditt EP, Barrett TB, McDougall JK (1983) Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci USA 80:6386-6389
6. Benjamin IJ, McMillan DR (1998) Stress (heat shock) proteins molecular chaperones in cardiovascular biology and disease. Circ Res 83:117-132
7. Braunwald E (1989) Unstable angina. A classification. Circulation 80:410-414
8. Braunwald E (1997) Shattuck lecture - cardiovascular medicine at the turn of the millenium: triumphs, concerns, and opportunities. N Engl J Med 337:1360-1369
9. Danesh J, Peto R (1998) Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 316:1130-1132
10. Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Wong Y, Bernardes-Silva M, Ward M (2000) Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ 321:208-213
11. Epstein SE, Zhou YF, Zhu J (1999) Infection and atherosclerosis. Emerging mechanistic paradigms. Circulation 100:e20-e28
12. Epstein SE (2002) The multiple mechanisms by which infection may contribute to atherosclerosis development and course. Circ Res 90:2-4
13. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G, Victor A, Hafner G, Schlumberger W, Meyer J (2002) Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 105:15-21
14. Frostegård J, Kjellman B, Gidlund M, Andersson B, Jindal S, Kiessling R (1996) Induction of heat shock protein in monocytic cells by oxidized low density lipoprotein. Atherosclerosis 12:93-103
15. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC (1996) Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 64:1614-1620
16. Gupta S, Leatham EW, Carrigton D, Mendall MA, Kaski JC, Camm J (1997) Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 96:404-407
17. Gurfinkel E, Bozovich G, Beck E, Testa E, Livellara B, Mautner B (1999) Treatment with the antibiotic roxythromycin in patients with acute non-Q-wave coronary syndromes. Eur Heart J 20:121-127
18. Hochleitner BW, Hochleitner EO, Obrist P, Eberl T, Amberger A, Xu Q, Margreiter R, Wick G (2000) Fluid shear stress induces heat shock protein 60 expression in endothelial cells in vitro and in vivo. Arterioscler Thromb Vasc Biol 20:617-623
19. Huittinen T, Leinonen M, Tenkanen L, Mänttäri M, Virkkunen H, Pitkänen T, Wahlström E, Palosuo T, Manninen V, Saikku P (2002) Autoimmunity to human heat shock protein 60, Chlamydia pneumoniae infection, and inflammation in predicting coronary risk. Arterioscler Thromb Vasc Biol 22:431-437
20. Kol A, Bourcier T, Lichtman AH, Libby P (1999) Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 103:571-577
21. Kol A, Sukhova GK, Lichtman AH, Libby P (1998) Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-a and matrix metalloproteinase expression. Circulation 98:300-307
22. Maass M, Bartels C, Engel PM, Mamat U, Sievers HH (1998) Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 31:827-832
23. Mach F, Sukhova GK, Michetti M, Libby P, Michetti P (2002) Influence of Helicobacter pylori infection during atherogenesis in vivo in mice. Circ Res 90:1-4
24. Mayr M, Metzler B, Kiechl S, Willeit J, Schett G, Xu Q, Wick G (1999) Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae. Immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation 99:1560-1566
25. Muhlestein JB, Anderson JL, Carlquist JF, Salunkhe K, Horne BD, Pearson RR, Bunch TJ, Allen A, Trehan S, Nielson C (2000) Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. Circulation 102:1755-1760
26. Muhlestein JB, Anderson JL, Hammond EH, Zhao L, Trehan S, Schwobe EP, Carlquist JF (1998) Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 97:633-636
27. Muhlestein JB, Hammond EH, Carlquist JF, Radicke E, Thomson MJ, Karagounis LA, Woods ML Anderson JL (1996) Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Cardiol 27:1555-1561
28. Prasad A, Zhu J, Halcox JPJ, Waclawiw MA, Epstein SE, Quyyumi AA (2002) Predisposition to atherosclerosis by infections. Role of endothelial dysfunction. Circulation 106:184-190
29. Rupprecht HJ, Blankenberg S, Bickel C, Rippin G, Hafner G, Prellwitz W, Schlumberger W, Meyer J (2001) Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 104:25-31
30. Schett G, Metzler B, Mayr M, Amberger A, Niederwieser D, Gupta RS, Mizzen L, Xu Q, Wick G (1997) Macrophage-lysis mediated by autoantibodies to heat shock protein 65/60. Atherosclerosis 128:27-38
31. Sinisalo J, Mattila K, Valtonen V, Anttonen O, Juvonen J, Melin J, Vuorinen-Markkola H, Nieminen MS (2002) Effect of 3 months of antimicrobial treatment with clarithromycin in acute non-Q-wave coronary syndrome. Circulation 105:1555-1560
32. Stone AFM, Mendall MA, Kaski JC, Edger TM, Risley P, Poloniecki J, Camm J, Northfield TC (2002) Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes. South thames trial of antibiotics in myocardial infarction and unstable angina (STAMINA). Circulation 106:1219-1223
33. Xu Q, Schett G, Perschinka H, Mayr M, Egger G, Oberhollenzer F, Willeit J, Kiechl S, Wick G (2000) Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 102:14-20
34. Xu Q, Schett G, Seitz CS, Hu Y, Gupta RS, Wick G (1994) Surface staining and cytotoxic activity of heat-shock protein 60 antibody in stressed aortic endothelial cells. Circ Res 75:1078-1085
35. Zahn R, Schneider S, Frilling B, Seidl K, Tebbe U, Weber M, Gottwik M, Altmann E, Seidel F, Rox J, Höffler U, Neuhaus K-L, Senges J (2003) Antibiotic Therapy after acute myocardial infarction. A prospective randomized study. Circulation 107:1253-1259
36. Zhu J, Nieto J, Horne BD, Anderson JL, Muhlestein JB, Epstein SE (2001) Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 103:45-51
37. Zhu J, Quyyumi AA, Norman JE, Csako G, Waclawiw MA, Shearer GM, Epstein SE (2000) Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol 85:140-146
38. Zhu J, Quyyumi AA, Rott D, Csako G, Wu H, Halcox J, Epstein SE (2001) Antibodies to human heat shock protein 60 are associated with the presence and severity of coronary artery disease. Evidence for an autoimmune component of atherogenesis. Circulation 103:1071-1075